Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: The relationship to triglyceride-rich postprandial lipoprotein composition

Atherosclerosis

Volumn 187, Issue 1, 2006, Pages 57-64

  Phillips, Catherine ^a   Mullan, Karen ^a   Owens, Daphne ^a   Tomkin, Gerald H ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Apo B100; Apo B48; Microsomal triglyceride transfer protein (MTP); Statins; Triglyceride rich lipoproteins; Type 2 diabetes

Indexed keywords

APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; CHYLOMICRON; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PHOSPHOLIPID; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ARTICLE; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA RESPONSIVE ELEMENT; DRUG EFFECT; DUODENUM BIOPSY; DUODENUM MUCOSA; FEMALE; GASTROSCOPY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; RIBONUCLEASE PROTECTION ASSAY; TREATMENT OUTCOME;

BIOPSY; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHOLESTEROL; CHYLOMICRONS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTESTINES; LIPOPROTEINS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; RIBONUCLEASES; RNA, MESSENGER; TRIGLYCERIDES;

EID: 33744812746     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.08.020     Document Type: Article

References (34)

1. Wetterau J.R., Aggerbeck L.P., Bouma M.E., et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science 258 (1992) 999-1001
2. Shoulders C.C., Brett D.J., Bayliss J.D., et al. Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum Mol Genet 2 (1990) 2109-2116
3. Hagan D.L., Kienzle B., Jamil H., et al. Transcriptional regulation of human and hamster microsomal triglyceride transfer protein genes. Cell type-specific expression and response to metabolic regulators. J Biol Chem 269 (1994) 28737-28744
4. Lin M.C., Gordon D., and Wetterau J.R. Microsomal triglyceride transfer protein (MTP) regulation in HepG2 cells: insulin negatively regulates MTP gene expression. J Lipid Res 36 (1995) 1073-1081
5. Gleeson A., Anderton K., Owens D., et al. The role of microsomal triglyceride transfer protein and dietary cholesterol in chylomicron production in diabetes. Diabetologia 42 (1999) 944-949
6. Phillips C., Anderton K., Bennett A., et al. Intestinal rather than hepatic microsomal triglyceride transfer protein as a cause of postprandial dyslipidaemia in diabetes. Metabolism 51 (2002) 847-852
7. Phillips C., Owens D., Collins P., et al. Microsomal triglyceride transfer protein: does insulin resistance play a role in the regulation of chylomicron assembly?. Atherosclerosis 160 (2002) 355-360
8. Lewis G.F., Uffelman K., Naples M., et al. Intestinal lipoprotein overproduction, a newly recognized component of insulin resistance, is ameliorated by the insulin sensitizer rosiglitazone: studies in the fructose-fed Syrian Golden hamster. Endocrinology 146 (2005) 247-255
9. Curtin A., Deegan P., Owens D., et al. Alterations in apolipoprotein B48 in the postprandial state. Diabetologia 37 (1994) 1259-1262
10. Curtin A., Deegan P., Owens D., et al. Elevated triglyceride-rich lipoproteins in diabetes. A study of apolipoprotein B-48. Acta Diabetol 33 (1995) 205-210
11. Pal S., Semorine K., Watts G.F., et al. Identification of lipoproteins of intestinal origin in human atherosclerotic plaque. Clin Chem Lab Med 41 (2003) 792-795
12. Proctor S.D., Vine D.F., and Mamo J.C. Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Atheroscler Thromb Vasc Biol 11 (2004) 2162-2167
13. Blackburn P., Cote M., Lamarche B., et al. Impact of postprandial variation in triglyceridemia on low-density lipoprotein particle size. Metabolism 52 (2003) 1379-1386
14. Takayanagi N., Onuma T., Kato S., et al. Association between LDL particle size and postprandial increase of remnant-like particles in Japanese type 2 diabetic patients. Diab Res Clin Pract 66 (2004) 245-252
15. Rumley A.G., Woodward M., Rumley A., et al. Plasma lipid peroxides: relationships to cardiovascular risk factors and prevalent cardiovascular disease. QJM 97 (2004) 809-816
16. Betula S.B., Fitzsimons O., Moreno S., et al. Post-prandial apolipoprotein B48 and B100-containing lipoproteins in Type 2 diabetes: do statins have a specific effect on triglyceride metabolism?. Metabolism 49 (2000) 1-7
17. Westphal S., Wiens L., Guttler K., et al. Chylomicron remnants of various sizes are lowered more effectively by fenofibrate than by atorvastatin in patients with combined hyperlipidemia. Atherosclerosis 171 (2003) 369-377
18. Dane-Stewart C.A., Watts G.F., Pal S., et al. Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease. Metabolism 52 (2003) 1279-1286
19. Parhofer K.G., Barrett P.J., and Schwandt P. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemic subjects. J Clin Endcrinol Metab 85 (2000) 4224-4230
20. Phillips C., Murugasu G., Owens D., et al. Improved metabolic control reduces the number of postprandial apolipoprotein B48-containing particles in Type 2 diabetes. Atherosclerosis 148 (2000) 283-291
21. Karpe F., and Hamsten A. Determination of apolipoproteins B48 and B100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 35 (1994) 1311-1317
22. Au W.S., Kung H.F., and Lin M.C. Regulation of microsomal triglyceride transfer protein gene by insulin in HepG2 cells: roles of MAPKerk and MAPKp38. Diabetes 52 (2003) 1073-1080
23. Phillips C, Owens D, Collins P, et al. Low density lipoprotein non-esterified fatty acids and lipoprotein lipase in diabetes, Atherosclerosis 2005;181:109-14.
24. Sato R., Miyamoto W., Inoue J., et al. Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription. J Biol Chem 274 (1999) 24714-24720
25. Kulinski A., Rustaeus S., and Vance J.E. Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. J Biol Chem 277 (2002) 31516-31525
26. Hussein M.M. A proposed model for the assembly of chylomicrons. Atherosclerosis 148 (2000) 1-15
27. Taskinen M.R. Pathogenesis of dyslipidaemia in type 2 diabetes. Exp Clin Endocrinol Diab 109 (2001) S180-S188
28. Mero N., Malmstrom R., Steiner G., et al. Postprandial metabolism of apolipoprotein B-48 and B-100 containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease. Atherosclerosis 150 (2000) 167-177
29. Wilhelm M.G., and Cooper A.D. Induction of atherosclerosis by human chylomicron remnants: a hypothesis. J Atheroscler Thromb 10 (2003) 132-139
30. Martins I.J., Mortimer B.-C., Miller J., et al. Effects of particle size and number on the plasma clearance of chylomicrons and remnants. J Lipid Res 37 (1996) 2696-2705
31. Lahdenpera S., Syvanne M., Kahri J., et al. Regulation of low density lipoprotein particle size and distribution in NIDDM and coronary artery disease: importance of serum triglycerides. Diabetologia 39 (1996) 453-461
32. Koba S., Hirano T., Murayama S., et al. Small dense LDL phenotype is associated with postprandial increases of large VLDL and remnant-like particles in patients with acute myocardial infarction. Atherosclerosis 170 (2003) 131-140
33. Ueshima K., Akihisa-Umeno H., Sawada M., et al. Possible involvement of enhanced intestinal microsomal triglyceride transfer protein (MTP) gene expression in acceleration of lipid absorption by a western-type diet in apolipoprotein E knockout mice. Life Sci 26 (2004) 179-190
34. Ueshima K., Akihisa-Umeno H., Nagayoshi A., et al. Implitapide, a microsomal triglyceride transfer protein inhibitor, reduces progression of atherosclerosis in apolipoprotein E knockout mice fed a Western-type diet: involvement of the inhibition of postprandial triglyceride elevation. Biol Pharm Bull 28 (2005) 247-252